NYSE:EWMedical Equipment
Is Edwards Lifesciences (EW) Undervalued As TAVR And EVOQUE Growth Hopes Build?
Recent share price performance and business snapshot
Edwards Lifesciences (EW) stock has moved quietly higher, with the share price at US$90.75 as of the most recent close, and positive total returns over the past year and past 3 months.
The company reports annual revenue of US$6.5b and net income of US$979.9m, mainly from medical products that treat advanced cardiovascular diseases. Operations span the United States, Europe, Japan and other international markets.
Over the past month the...